Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries
Clinical trial NCT05849857 · RECRUITING
Trial details
- NCT number
- NCT05849857
- Sponsor
- Oslo University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2027-06-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.